advertise

Tuesday, 30 September 2014

China Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Industry 2014-2018 - Market size, shares, trend, growth, research and statistics

China is the world's largest producer and consumer of pork with the output volume of pork accounting for nearly 50% of the total. The output volume of pork was 54.93 million tons in China in 2013, up by 2.8% YOY. The livestock volume of pigs was 474.11 million, down by 0.4% YOY while the stock volume of fattened pigs was 715.57 million, up by 2.5% YOY.

To Brows a Full Report with Toc:
 http://www.researchmoz.us/research-report-on-china-porcine-reproductive-and-respiratory-syndrome-prrs-vaccine-industry--2014-2018-report.html

The PRRS broke out in southern China and spread rapidly nationwide after summer in 2006, which lead to increases in mortality rate of piglets and pork prices and significant decrease in output volume of pork. In May 2007, the Ministry of Agriculture of China approved the production of highly-pathogenic porcine reproductive and respiratory syndrome inactivated vaccine (NVDC-JXA1) in six manufacturers of biological products. Porcine reproductive and respiratory syndrome (PRRS) remains one of the key compulsory immunity diseases in China.

According to National Compulsory Immunization Plan of Animal Epidemic Diseases in 2014 issued by Ministry of Agriculture of China, the government conducts compulsory immunizations against 4 diseases, including highly-pathogenic PRRS. The government is responsible for the expenses. Currently highly pathogenic PRRS vaccines are purchased by the government through invitation for bidding in China.

The market competition is intensive in the PRRS vaccine industry in China. There are 26 manufacturers of PRRS vaccines in China, including Dahuanong, Xinjiang Tecon Animal Husbandry Bio-Technology Co., Ltd., Qingdao Yebio Bioengineering Co., Ltd. and Inner Mongolia Jinyu Group Stock Company. In terms of the direct sales of high-end vaccines, the PRRS vaccines of Zoetis went to the market in Guangzhou at the end of August 2013 after Boehringer. These foreign-funded vaccine brands occupy the market shares using the brand advantages, which intensify the market competition.

As Chinese economy develops and the living standards increase, the demand for pork will continue to grow, which promotes the development of pig raising industry. The market size of PRRS vaccines will continue to increase in China in the next few years, which attract many animal health enterprises' attention.

Through this report, the readers can acquire the following information:

Incidence Status of Porcine Reproductive and Respiratory Syndrome
Status of China Breeding Industry
Policy Environment and Government Procurement of PRRS Vaccines in China
Supply and Demand Status of PRRS Vaccines in China
Major Manufacturers of PRRS Vaccines and the Operation Status in China
Prospect of China PRRS Vaccine Industry in China

The Following Enterprises and People Are Recommended to Purchase This Report:

Manufacturers and Trading Enterprises of Animal Vaccines
Breeding Enterprises
Management Organizations of Livestock Industry
Investors and Research Institutes Concerned about PRRS Vaccine Industry

All Repoers of this Category Here: http://www.researchmoz.us/vaccines-market-reports-79.html

About ResearchMoz

ResearchMoz is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price.

Contact US: 


For More Information Kindly Contact:
Email: sales@researchmoz.us
Website @ http://www.researchmoz.us/

No comments:

Post a Comment